A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions
Thursday, December 17, 2020
Rituximab – USA
On Dec. 16, 2020, Federal Circuit affirmed (Rule 36
judgment) PTAB finding method of use patent invalid as obvious.You can find the
IPR details reported “"here"” on this blog.
No comments:
Post a Comment